Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil with Chemoradiotherapy for IDH-wildtype Astrocytoma
NCT04757662Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- May 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tadalafil in astrocytoma and glioblastoma (GBM), sponsored by Washington University School of Medicine. Primary endpoints: Relative change of MDSCs in peripheral blood and Frequency of adverse events as measured by CTCAE v5.0. Started May 2021; status: completed.
02
Drugs
tadalafil
03
Conditions
astrocytomaglioblastoma (GBM)
Beyond the preview
Go deeper on NCT04757662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04757662.